HMP CME (Audio)

Stephen B. Hanauer, MD, FACG: Optimizing Biological Therapies in the Modern Era

David Binion, MD, FACG, Francis A. Farraye, MD, MSc, FACG, and Constantine Tsigrelis, MD: C. Difficile in IBD: Faculty Discussion and Case Studies

Gary R. Lichtenstein, MD, FACG: Understanding Iron Deficiency Anemia in Gastroenterology: Who and Why?

Stephen B. Hanauer, MD, FACG: Iron Deficiency Anemia in GI Disorders: Introduction and Case Presentations

Millie D. Long, MD, MPH, FACG: Reaching Beyond Anti-TNFs in Moderate to Severe Ulcerative Colitis

Patient-Centric Approaches to Bone Healing - Robert D. Zura, MD

Game-Changing Potential of MRD in Hematological Malignancies - Prashant Kapoor, MD

Panel Discussion: Hairy Cell Leukemia - Jacqueline C. Barrientos, MD, MS and Jae Park, MD

Minimal Residual Disease Detection, Single Cell RNA Seq., Cell Free DNA, etc: Does it Impact Treatment? - Rafael Fonseca, MD

MRD Detection, Single Cell RNA Seq., Cell Free DNA, etc: Does it Impact Treatment? - Rafael Fonseca, MD

Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management - Edward Kim, MD, FSIR; Gennaro Selvaggi, MD, FACS; Richard Kim, MD

Advancing the Management of Insomnia: Diagnostic and Therapeutic Strategies for Success Sleep Disorders; Psychopharmacology - Karl Doghramji, MD and David N. Neubauer, MD

Next-Generation Neurosteroids for the Treatment of Major Depressive Disorder: Neurobiology and Pathophysiology - Vladimir Maletic, MD, MS and C. Brendan Montano, MD

The Monster Under the BED: Revealing Binge Eating Disorder from a Clinical and a Patient Perspective - Leslie Citrome, MD, MPH and C. Brendan Montano, MD

Biliary Cancer: Novel Agents and Targets - Ghassan Abou-Alfa, MD, MBA

Colorectal Cancer: An Update Novel Agents and Targets - Scott Kopetez, MD, PhD

Colorectal Cancer: Sequencing and Therapeutic Approaches in First- and Next-Line Treatment - Axel Grothey, MD

Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019 - Fadi Saab, MD and Jihad Mustapha, MD

Tardive Dyskinesia: Practical Strategies for Patient Follow-Up and Long-Term VMAT2 Inhibitor Treatment -

Assessing the Role of Omega-3s for Cardiovascular Risk Reduction in Patients with Dyslipidemia: A Managed Care Perspective - Deepak L. Bhatt, MD, MPH and Eric Cannon, PharmD, FAMCP